These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 25490144)

  • 41. Ovarian expression of insulin-like growth factor-I (IGF-I), IGF binding proteins, and growth hormone (GH) receptor in heifers actively immunized against GH-releasing factors.
    Cohick WS; Armstrong JD; Whitacre MD; Lucy MC; Harvey RW; Campbell RM
    Endocrinology; 1996 May; 137(5):1670-7. PubMed ID: 8612500
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Insulin resistance is associated with increased serum concentration of IGF-binding protein-related protein 1 (IGFBP-rP1/MAC25).
    López-Bermejo A; Khosravi J; Fernández-Real JM; Hwa V; Pratt KL; Casamitjana R; Garcia-Gil MM; Rosenfeld RG; Ricart W
    Diabetes; 2006 Aug; 55(8):2333-9. PubMed ID: 16873698
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Free and total insulin-like growth factor I (IGF-I), IGF-binding protein-1 (IGFBP-1), and IGFBP-3 and their relationships to the presence of diabetic retinopathy and glomerular hyperfiltration in insulin-dependent diabetes mellitus.
    Janssen JA; Jacobs ML; Derkx FH; Weber RF; van der Lely AJ; Lamberts SW
    J Clin Endocrinol Metab; 1997 Sep; 82(9):2809-15. PubMed ID: 9284701
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Differential impacts of insulin-like growth factor-binding protein-3 (IGFBP-3) in epithelial IGF-induced lung cancer development.
    Kim WY; Kim MJ; Moon H; Yuan P; Kim JS; Woo JK; Zhang G; Suh YA; Feng L; Behrens C; Van Pelt CS; Kang H; Lee JJ; Hong WK; Wistuba II; Lee HY
    Endocrinology; 2011 Jun; 152(6):2164-73. PubMed ID: 21447628
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Diagnostic value of the acid-labile subunit in acromegaly: evaluation in comparison with insulin-like growth factor (IGF) I, and IGF-binding protein-1, -2, and -3.
    Arosio M; Garrone S; Bruzzi P; Faglia G; Minuto F; Barreca A
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1091-8. PubMed ID: 11238491
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Alteration in pancreatic immunoreactivity of insulin-like growth factor (IGF)-binding protein (IGFBP)-6 and in intracellular degradation of IGFBP-3 in fibroblasts of IGF-II receptor/IGF-II-deficient mice.
    Braulke T; Dittmer F; Götz W; von Figura K
    Horm Metab Res; 1999; 31(2-3):235-41. PubMed ID: 10226807
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age.
    Morales AJ; Nolan JJ; Nelson JC; Yen SS
    J Clin Endocrinol Metab; 1994 Jun; 78(6):1360-7. PubMed ID: 7515387
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evidence of a role for insulin-like growth factor binding protein (IGFBP)-3 in metabolic regulation.
    Yamada PM; Mehta HH; Hwang D; Roos KP; Hevener AL; Lee KW
    Endocrinology; 2010 Dec; 151(12):5741-50. PubMed ID: 20926583
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Glucose intolerance and pancreatic β-cell dysfunction in the anorectic anx/anx mouse.
    Lindfors C; Katz A; Selander L; Johansen JE; Marconi G; Schalling M; Hökfelt T; Berggren PO; Zaitsev S; Nilsson IA
    Am J Physiol Endocrinol Metab; 2015 Aug; 309(4):E418-27. PubMed ID: 26126683
    [TBL] [Abstract][Full Text] [Related]  

  • 50. IGF-binding protein-2 protects against the development of obesity and insulin resistance.
    Wheatcroft SB; Kearney MT; Shah AM; Ezzat VA; Miell JR; Modo M; Williams SC; Cawthorn WP; Medina-Gomez G; Vidal-Puig A; Sethi JK; Crossey PA
    Diabetes; 2007 Feb; 56(2):285-94. PubMed ID: 17259371
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Short-term administration of an angiotensin-receptor antagonist in patients with impaired fasting glucose improves insulin sensitivity and increases free IGF-I.
    Zandbergen AA; Lamberts SW; Janssen JA; Bootsma AH
    Eur J Endocrinol; 2006 Aug; 155(2):293-6. PubMed ID: 16868143
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Impaired glucose homeostasis in insulin-like growth factor binding protein-1 transgenic mice.
    Rajkumar K; Krsek M; Dheen ST; Murphy LJ
    J Clin Invest; 1996 Oct; 98(8):1818-25. PubMed ID: 8878433
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Relationship of Serum Total Insulin-Like Growth Factor Binding Protein-3 with Insulin-Like Growth Factor-I and Glucose Tolerance in Korean Children and Adolescents.
    Kim SY; Kim M; Oh Y; Lee DY
    Int J Endocrinol; 2021; 2021():9966114. PubMed ID: 34239560
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pancreatic adipose tissue infiltration, parenchymal steatosis and beta cell function in humans.
    Begovatz P; Koliaki C; Weber K; Strassburger K; Nowotny B; Nowotny P; Müssig K; Bunke J; Pacini G; Szendrödi J; Roden M
    Diabetologia; 2015 Jul; 58(7):1646-55. PubMed ID: 25740696
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Phenotypic manifestations of insulin-like growth factor binding protein-1 (IGFBP-1) and IGFBP-3 overexpression in transgenic mice.
    Murphy LJ; Rajkumar K; Molnar P
    Prog Growth Factor Res; 1995; 6(2-4):425-32. PubMed ID: 8817686
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of des-acyl ghrelin on adiposity and glucose metabolism.
    Zhang W; Chai B; Li JY; Wang H; Mulholland MW
    Endocrinology; 2008 Sep; 149(9):4710-6. PubMed ID: 18535105
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Loss of OcaB Prevents Age-Induced Fat Accretion and Insulin Resistance by Altering B-Lymphocyte Transition and Promoting Energy Expenditure.
    Carter S; Miard S; Caron A; Sallé-Lefort S; St-Pierre P; Anhê FF; Lavoie-Charland E; Blais-Lecours P; Drolet MC; Lefebvre JS; Lacombe J; Deshaies Y; Couet J; Laplante M; Ferron M; Bossé Y; Marette A; Richard D; Marsolais D; Picard F
    Diabetes; 2018 Jul; 67(7):1285-1296. PubMed ID: 29496744
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Vascular endothelial function and blood pressure homeostasis in mice overexpressing IGF binding protein-1.
    Wheatcroft SB; Kearney MT; Shah AM; Grieve DJ; Williams IL; Miell JP; Crossey PA
    Diabetes; 2003 Aug; 52(8):2075-82. PubMed ID: 12882925
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Selective disruption of dopamine D2 receptors in pituitary lactotropes increases body weight and adiposity in female mice.
    Perez Millan MI; Luque GM; Ramirez MC; Noain D; Ornstein AM; Rubinstein M; Becu-Villalobos D
    Endocrinology; 2014 Mar; 155(3):829-39. PubMed ID: 24424036
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Engineered IGF-I expression induces glandular enlargement in the murine prostate.
    Konno-Takahashi N; Takeuchi T; Shimizu T; Nishimatsu H; Fukuhara H; Kamijo T; Moriyama N; Tejima S; Kitamura T
    J Endocrinol; 2003 Jun; 177(3):389-98. PubMed ID: 12773119
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.